Lv5
1040 积分 2025-04-08 加入
FIH dose selection beyond MABEL: Optimizing phase 1 clinical trial starting dose whilst protecting patient safety
9天前
已完结
Fatal tumor lysis syndrome in a pediatric patient with acute lymphoblastic leukemia treated with venetoclax
1个月前
已完结
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
3个月前
已完结
Practical Considerations in Determining Adversity and the No-Observed-Adverse-Effect-Level (NOAEL) in Nonclinical Safety Studies: Challenges, Perspectives and Case Studies
3个月前
已完结
Points to consider regarding the use and implementation of virtual controls in nonclinical general toxicology studies
3个月前
已完结
Replacing concurrent controls with virtual control groups in rat toxicity studies
3个月前
已完结
Recovery Animals in Toxicology Studies: An Innovation and Quality Consortium Perspective on Best Practices With Case Study Examples
3个月前
已完结
Historical Control Data
3个月前
已完结
皖公网安备34019202002308
